A Post-authorization Safety Study to Evaluate the Safety of Multiple Myeloma Patients Treated with Ciltacabtagene Autoleucel

18/10/2022
03/06/2025
EU PAS number:
EUPAS49370
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

23May2024-REDACTED_Protocol-FD-68284528MMY4009-588202_946738 (1).pdf

English (3.87 MB - PDF) View document
Updated protocol

28May2025-Redacted_Protocol-Amend-1-FD-68284528MMY4009-588202 (4).pdf

First published: 28/05/2025
English (1.91 MB - PDF) View document
Study results
Study report
Other information